Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance, According to Hagens Berman
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in Snap after its stock fell 17% from ad platform issues and alleged misleading statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.